Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPISODE III aspirin trial in stage III colorectal cancer
jRCTs031180009Active, not recruiting
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Apr 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in colorectal cancer (CRC) comparing Placebo with Aspirin (2 arms). Primary endpoint: Disease-free survival. Started Apr 2018; status: active, not recruiting.
02
Drugs
aspirin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on jRCTs031180009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180009.